Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Noncytotoxic thiocolchicine derivatives useful as muscle relaxants

Nov. 10, 1998

Compounds acting on metabotropic glutamate receptors disclosed by Lilly

Nov. 10, 1998

Novel compounds from ADIR acting on the dopaminergic system

Nov. 10, 1998

New 5-HT1A receptor antagonist from Astra Arcus undergoes extensive preclinical testing

Nov. 9, 1998

Neuroprotective agents with dual NOS-inhibitory and antioxidant effects synthesized at French lab

Nov. 9, 1998

NPS-2390: representative of a novel class of potent and selective group I mGluR antagonists

Nov. 9, 1998

In vitro and in vivo pharmacology of CP-465022 presented at neuroscience meeting

Nov. 9, 1998

Novel proteasome inhibitor effective in animal model of stroke

Nov. 9, 1998

Effects of new free radical scavenger MDL-100002 in embolic stroke

Nov. 9, 1998

Centrally selective nAChR ligand from R.J. Reynolds considered Alzheimer's disease candidate

Nov. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....